| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
|
| | NHS-PEG4-(m-PEG4)3-ester Basic information |
| Product Name: | NHS-PEG4-(m-PEG4)3-ester | | Synonyms: | NHS-PEG4-(m-PEG4)3-ester;9,12,15,18,25,32,35,38,41-Nonaoxa-6,22,29-triazadotetracontanoic acid, 5,21,28-trioxo-23,23-bis(5-oxo-2,9,12,15,18-pentaoxa-6-azanonadec-1-yl)-, 2,5-dioxo-1-pyrrolidinyl ester;Succinimidyl-PEG(4)-[PEG(4)-OMe]3 | | CAS: | 1333154-70-3 | | MF: | C60H110N6O28 | | MW: | 1363.54 | | EINECS: | | | Product Categories: | | | Mol File: | 1333154-70-3.mol |  |
| | NHS-PEG4-(m-PEG4)3-ester Chemical Properties |
| density | 1.22±0.1 g/cm3(Predicted) | | pka | 13.65±0.46(Predicted) |
| | NHS-PEG4-(m-PEG4)3-ester Usage And Synthesis |
| Uses | NHS-PEG4-(m-PEG4)3-ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | NHS-PEG4-(m-PEG4)3-ester Preparation Products And Raw materials |
|